politics #HealthCare #Policy #Alzheimer'sDiseaseInternational #Alzheimer’s #GLP1 #NovoNordisk #WeightLossDrugs GLP-1s fail to slow progression of Alzheimer’s: Novo Nordisk The Hill Tue